Atopic dermatitis is an inflammatory skin disease with a juvenile tendency (15% - 20%) of cases with a chronic component that could justify the prevalence in adults (7%). Thus, eczematous-type lesions characterize it across various ethnic phenotypes. This pathology is well known in Europe, America, and Asia, but in Africa, especially in sub-Saharan Africa, poor data are available about atopic dermatitis immunopathology. In this African context, we proceeded to study the physiopathology of this pathology by evaluating the activation levels of immune cells, more specifically the level of lymphocyte activation and the membrane expression levels of the FcεRI-IgE complex on granulocytic cells. Our study is conducted from a descriptive and analytical case-control perspective over a period of 3 months, from December 2, 2021, to March 2, 2022, at Le Dantec medical center. The study population was diagnosed in the dermatology department by specialists based on the analysis of their clinical symptoms with the United Kingdom Working Party (SCORAD, CLDQI/DLQI); Statistical data were carried out using non-parametric tests with significance relief at p < 0.05. Cell analysis was done by flow cytometry with the SYSMEX Cube 8 to assess their activation through membrane expression of the complex FcεRI-IgE on granulocytes and lymphocytes. Overall, neutrophils are the most important cells in patients and healthy subjects, and normal blood lymphocyte levels were observed; no significant differences were observed between patients and controls in these two cell populations. TCD8+ populations are the most blood lymphoid cells isolated (p < 0.001). The levels of eosinophils and basophils obtained in the patients were found to be the highest (p: 0.018; p: 0.149); however, they presented low levels of activation characterized by low membrane expression of FcεRI-IgE on granulocytes. Correlations between disease evolution and IgE/RfcE1 membrane expressions on basophils were found (R0 = 0.640; p < 0.05; Ro: 0.603, p: 0.027). Indeed, basophils and eosinophils expressing membrane IgE had a similar trend (Ro: 0.634, p: 0.0231). Our results are in contradiction with studies conducted on Afro-Americans and South Africans, in which the Th2 immune response was dominant. This is a preliminary study on A.D in Senegal, so we need to be cautious with these results, given the small number of patients and the need for further immunological and genetic investigations.
References
[1]
Heratizadeh, A., Werfel, T. and R?sner, L.M. (2015) Adaptive Immunantworten und damit verbundene Triggerfaktoren bei atopischer Dermatitis. DerHautarzt, 66, 96-102. https://doi.org/10.1007/s00105-014-3559-8
[2]
Kraft, M.T. and Prince, B.T. (2019) Atopic Dermatitis Is a Barrier Issue, Not an Allergy Issue. Immunology and Allergy Clinics of North America, 39, 507-519. https://doi.org/10.1016/j.iac.2019.07.005
[3]
Reguia?, Z. (2017) Dermatite atopique de l’adulte: Présentation clinique, complications et comorbidités. Annales de Dermatologie et de Vénéréologie, 144, VS15-VS22. https://doi.org/10.1016/s0151-9638(18)30087-5
[4]
Bussmann, C., Weidinger, S. and Novak, N. (2011) Genetics of Atopic Dermatitis. JDDG: Journal der DeutschenDermatologischen Gesellschaft, 9, 670-676. https://doi.org/10.1111/j.1610-0387.2011.07656.x
[5]
Cabanillas, B., Brehler, A. and Novak, N. (2017) Atopic Dermatitis Phenotypes and the Need for Personalized Medicine. Current Opinion in Allergy & Clinical Immunology, 17, 309-315. https://doi.org/10.1097/aci.0000000000000376
[6]
Furue, M., Chiba, T., Tsuji, G., Ulzii, D., Kido-Nakahara, M., Nakahara, T., et al. (2017) Atopic Dermatitis: Immune Deviation, Barrier Dysfunction, IgE Autoreactivity and New Therapies. Allergology International, 66, 398-403. https://doi.org/10.1016/j.alit.2016.12.002
[7]
Czarnowicki, T., He, H., Krueger, J.G. and Guttman-Yassky, E. (2019) Atopic Dermatitis Endotypes and Implications for Targeted Therapeutics. Journal of Allergy and Clinical Immunology, 143, 1-11. https://doi.org/10.1016/j.jaci.2018.10.032
[8]
Makowska, K., Nowaczyk, J., Blicharz, L., Wa?kiel-Burnat, A., Czuwara, J., Olszewska, M., et al. (2023) Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments. International Journal of Molecular Sciences, 24, Article No. 781. https://doi.org/10.3390/ijms24010781
[9]
Brunner, P.M., Guttman-Yassky, E. and Leung, D.Y.M. (2017) The Immunology of Atopic Dermatitis and Its Reversibility with Broad-Spectrum and Targeted Therapies. Journal of Allergy and Clinical Immunology, 139, S65-S76. https://doi.org/10.1016/j.jaci.2017.01.011
[10]
Kaufman, B.P., Guttman-Yassky, E. and Alexis, A.F. (2018) Atopic Dermatitis in Diverse Racial and Ethnic Groups—Variations in Epidemiology, Genetics, Clinical Presentation and Treatment. Experimental Dermatology, 27, 340-357. https://doi.org/10.1111/exd.13514
[11]
Tanei, R. (2020) Atopic Dermatitis in Older Adults: A Review of Treatment Options. Drugs & Aging, 37, 149-160. https://doi.org/10.1007/s40266-020-00750-5
[12]
Mayba, J.N. and Gooderham, M.J. (2017) Review of Atopic Dermatitis and Topical Therapies. Journal of Cutaneous Medicine and Surgery, 21, 227-236. https://doi.org/10.1177/1203475416685077
[13]
Reed, B. and Blaiss, M.S. (2018) The Burden of Atopic Dermatitis. Allergy and Asthma Proceedings, 39, 406-410. https://doi.org/10.2500/aap.2018.39.4175
[14]
Adamson, A.S. (2017) The Economics Burden of Atopic Dermatitis. In: Fortson, E.A., et al., Eds., Management of Atopic Dermatitis, Springer International Publishing, 79-92. https://doi.org/10.1007/978-3-319-64804-0_8
[15]
Zrafi, A.W. (2019) La prévalence de la dermatite atopique dans la population générale du département de Pikine. Ph.D. Thesis, Université Cheikh Anta Diop.
[16]
Arahou, T. (2023) LA dermatite atopique a dakar: Une étude multicentrique portant sur 301 cas sur une période de 03 ans. Universite cheikh anta diop de Dakar.
[17]
Russell, G., Campbell, D., Fleming, S., Bodner, C., Devereux, G., Godden, D., et al. (2001) An Application of the United Kingdom Working Party Diagnostic Criteria for Atopic Dermatitis in Scottish Infants. Journal of Investigative Dermatology, 117, 1526-1530. https://doi.org/10.1046/j.0022-202x.2001.01579.x
[18]
Mouna, K., Ben Hamouda, M., Hichem, B., Lahouel, M., Monia, Y. and Jameleddine, Z. (2022) Evaluation of a Modified Version of the United Kingdom Working Party Diagnostic Criteria for Atopic Dermatitis in Tunisia. Dermatitis, 33, S119-S123. https://doi.org/10.1097/der.0000000000000966
[19]
Akan, A., Dibek-M?s?rl?o?lu, E., Civelek, E., Vezir, E. and Kocaba?, C.N. (2020) Diagnosis of Atopic Dermatitis in Children: Comparison of the Hanifin-Rajka and the United Kingdom Working Party Criteria. Allergologia et Immunopathologia, 48, 175-181. https://doi.org/10.1016/j.aller.2019.07.008
[20]
Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., et al. (2022) European Guideline (EuroGuiDerm) on Atopic Eczema: Part I—Systemic Therapy. Journal of the European Academy of Dermatology and Venereology, 36, 1409-1431. https://doi.org/10.1111/jdv.18345
[21]
Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., et al. (2022) European Guideline (EuroGuiDerm) on Atopic Eczema—Part II: Non-Systemic Treatments and Treatment Recommendations for Special ae Patient Populations. Journal of the European Academy of Dermatology and Venereology, 36, 1904-1926. https://doi.org/10.1111/jdv.18429
[22]
Sigg, N., Leducq, S., Barbarot, S., Staumont, D., Ertus, C., Hurson, C., et al. (2025) Recommandations fran?aises pour la prise en charge de la dermatite atopique. Annales de Dermatologie et de Vénéréologie-FMC, 5, 493-533. https://doi.org/10.1016/j.fander.2025.09.003
[23]
Ait Idir, K., Moubri, M. and Salhi, A. (2017) Prévalence et physiopathologie de la dermatite atopique: Mise au point et connaissances actuelles. Batna Journal of Medical Sciences, 4, 10-14. https://doi.org/10.48087/BJMSra.2017.4103
[24]
Ali, F., Vyas, J. and Finlay, A. (2020) Counting the Burden: Atopic Dermatitis and Health-Related Quality of Life. Acta DermatoVenereologica, 100, adv00161. https://doi.org/10.2340/00015555-3511
[25]
Braun, C., Vocanson, M., Nicolas, J.F. and Nosbaum, A. (2020) Physiopathologie de la dermatite atopique et des autres maladies atopiques: Une approche globale est-elle possible? Annales de Dermatologie et de Vénéréologie, 147, 11S4-11S11. https://doi.org/10.1016/s0151-9638(20)31082-6
[26]
Langan, S.M., Irvine, A.D. and Weidinger, S. (2020) Atopic Dermatitis. The Lancet, 396, 345-360. https://doi.org/10.1016/s0140-6736(20)31286-1
[27]
Bylund, S., Kobyletzki, L., Svalstedt, M. and Svensson, ?. (2020) Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta DermatoVenereologica, 100, adv00160. https://doi.org/10.2340/00015555-3510
[28]
Huang, E. and Ong, P.Y. (2018) Severe Atopic Dermatitis in Children. Current Allergy and Asthma Reports, 18, Article No. 35. https://doi.org/10.1007/s11882-018-0788-4
[29]
Fasseeh, A.N., Elezbawy, B., Korra, N., Tannira, M., Dalle, H., Aderian, S., et al. (2022) Burden of Atopic Dermatitis in Adults and Adolescents: A Systematic Literature Review. Dermatology and Therapy, 12, 2653-2668. https://doi.org/10.1007/s13555-022-00819-6
[30]
de Bruin-Weller, M., Gadkari, A., Auziere, S., Simpson, E.L., Puig, L., Barbarot, S., et al. (2020) The Patient-Reported Disease Burden in Adults with Atopic Dermatitis: A Cross-Sectional Study in Europe and Canada. Journal of the European Academy of Dermatology and Venereology, 34, 1026-1036. https://doi.org/10.1111/jdv.16003
[31]
Cheng, J., Wu, J.J. and Han, G. (2021) Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic Review. Dermatology and Therapy, 11, 707-717. https://doi.org/10.1007/s13555-021-00516-w
[32]
Wu, W., Chan, T.C. and Chu, C. (2022) Asian Type Atopic Dermatitis. CosmoDerma, 2, Article No. 48. https://doi.org/10.25259/csdm_47_2022
[33]
Barrett, M. and Luu, M. (2017) Differential Diagnosis of Atopic Dermatitis. Immunology and Allergy Clinics of North America, 37, 11-34. https://doi.org/10.1016/j.iac.2016.08.009
[34]
Kanda, N., Hoashi, T. and Saeki, H. (2019) The Roles of Sex Hormones in the Course of Atopic Dermatitis. International Journal of Molecular Sciences, 20, Article No. 4660. https://doi.org/10.3390/ijms20194660
[35]
Han, H., Roan, F. and Ziegler, S.F. (2017) The Atopic March: Current Insights into Skin Barrier Dysfunction and Epithelial Cell-Derived Cytokines. Immunological Reviews, 278, 116-130. https://doi.org/10.1111/imr.12546
[36]
Spergel, J.M. and Paller, A.S. (2003) Atopic Dermatitis and the Atopic March. Journal of Allergy and Clinical Immunology, 112, S118-S127. https://doi.org/10.1016/j.jaci.2003.09.033
[37]
Zheng, T., Yu, J., Oh, M.H. and Zhu, Z. (2011) The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. Allergy, Asthma and Immunology Research, 3, 67?73. https://doi.org/10.4168/aair.2011.3.2.67
[38]
Spergel, J.M. (2010) Epidemiology of Atopic Dermatitis and Atopic March in Children. Immunology and Allergy Clinics of North America, 30, 269-280. https://doi.org/10.1016/j.iac.2010.06.003
[39]
Herrant, M., Loucoubar, C., Boufkhed, S., Bassène, H., Sarr, F.D., Baril, L., et al. (2015) Risk Factors Associated with Asthma, Atopic Dermatitis and Rhinoconjunctivitis in a Rural Senegalese Cohort. Allergy, Asthma & Clinical Immunology, 11, Article No. 24. https://doi.org/10.1186/s13223-015-0090-0
[40]
Dégboé, B.E., Koudoukpo, C., Agbéssi, N., Akpadjan, F., Adégbidi, H. and Atadokpèdé, F. (2019) Facteurs environnementaux associés à la dermatite atopique de l’enfant et de l’adulte dans le service de dermatologie du centre national hospitalier et universitaire de Cotonou, Bénin. Annales de Dermatologie et de Vénéréologie, 146, A145. https://doi.org/10.1016/j.annder.2019.09.184
[41]
Boguniewicz, M. (2020) Biologics for Atopic Dermatitis. Immunology and Allergy Clinics of North America, 40, 593-607. https://doi.org/10.1016/j.iac.2020.06.004
[42]
Boguniewicz, M. and Leung, D.Y.M. (2011) Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation. Immunological Reviews, 242, 233-246. https://doi.org/10.1111/j.1600-065x.2011.01027.x
[43]
Al-Afif, K.A.M., Buraik, M.A., Buddenkotte, J., Mounir, M., Gerber, R., Ahmed, H.M., et al. (2019) Understanding the Burden of Atopic Dermatitis in Africa and the Middle East. Dermatology and Therapy, 9, 223-241. https://doi.org/10.1007/s13555-019-0285-2
[44]
Sanyal, R.D., Pavel, A.B., Glickman, J., Chan, T.C., Zheng, X., Zhang, N., et al. (2019) Atopic Dermatitis in African American Patients Is TH2/TH22-Skewed with TH1/TH17 Attenuation. Annals of Allergy, Asthma & Immunology, 122, 99-110.e6. https://doi.org/10.1016/j.anai.2018.08.024
[45]
Amat, F., Soria, A., Tallon, P., Bourgoin-Heck, M., Lambert, N., Deschildre, A., et al. (2018) New Insights into the Phenotypes of Atopic Dermatitis Linked with Allergies and Asthma in Children: An Overview. Clinical & Experimental Allergy, 48, 919-934. https://doi.org/10.1111/cea.13156
[46]
Noda, S., Suárez-Fari?as, M., Ungar, B., Kim, S.J., de Guzman Strong, C., Xu, H., et al. (2015) The Asian Atopic Dermatitis Phenotype Combines Features of Atopic Dermatitis and Psoriasis with Increased TH17 Polarization. Journal of Allergy and Clinical Immunology, 136, 1254-1264. https://doi.org/10.1016/j.jaci.2015.08.015
[47]
Lunjani, N., Kerbelker, T., Mdletshe, F.B., Hlela, C. and O’Mahony, L. (2024) Phenotypes, Endotypes and Genotypes of Atopic Dermatitis and Allergy in Populations of African Ancestry on the Continent and Diaspora. Frontiers in Allergy, 4, Article ID: 1203304. https://doi.org/10.3389/falgy.2023.1203304
[48]
Masson E. EM-Consulte. Dermatite atopique. https://www.em-consulte.com/article/1055833/dermatite-atopique
[49]
Bellon, N. (2023) Nouveautés dans la prise en charge de la dermatite atopique de l’enfant. Journal de Pédiatrie et de Puériculture, 36, 177-185. https://doi.org/10.1016/j.jpp.2023.06.001
[50]
Shah, N., Alhusayen, R., Walsh, S. and Shear, N.H. (2018) Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study. Journal of Cutaneous Medicine and Surgery, 22, 484-487. https://doi.org/10.1177/1203475418781336